Remission in 2 months in DMARD and John Bridge Therapy (JBT) refractory active Rheumatoid Arthritis cyclophosphamide + five-fluorouracil + infliximab (CyC + five-FU + IFX) without oral and intravenous in a 6 months prospective observational study - WHO-ILA

John Darmawan (Speaker), Rasker, J. J. (Speaker), Sunle Chen (Speaker), Syed Atiqu Haq (Speaker), Fereydoun Davatchi (Speaker)

    Activity: Talk or presentation › Oral presentation

    Description

    Plaats van uitgifte: Yokohama - Japan
    Period23 Sep 2008
    Event titleInternational Journal of Rheumatic diseases 2008; 11 (suppl1): A51 (ISSN 1756-1841
    Event typeConference
    LocationYokohama - Japan

    Keywords

    • METIS-252923